Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Erectile Dysfunction
Interventions: Nitric Oxide, Tadalafil, Placebo; Dietary Supplement · Drug · Other
Lead sponsor: RHA Investments Ltd; Industry
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Anorexia Nervosa, Atypical Anorexia Nervosa
Interventions: Ketamine infusion; Drug
Lead sponsor: Amanda Downey, MD; Other
Eligibility: 16 Years to 26 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders, Sexual Dysfunction, Urologic Disorders, Viral Illness
Interventions: PrimePro™/ PrimeMSK™; Biological
Lead sponsor: Thomas Advanced Medical LLC; Industry
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Culver City, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stress, Stress, Psychological, Stress, Physiological, Stress, Emotional, Stress Reaction
Interventions: Education Program, Think Well Program, Be Well Program, Eat Well Program, Sleep Well Program, Move Well Program; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 712 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pulmonary Disease, Chronic Obstructive, COPD, Chronic Obstructive Lung Disease, Bronchitis, Chronic, Pulmonary Emphysema
Interventions: Remote Health Monitoring; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 40 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Levator Ani Syndrome
Interventions: Nifedipine, Placebo Ointment Base; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Stress, Psychological, Stress, Emotional
Interventions: Maltreatment and Abuse Chronology of Exposure Scale as a stress challenge, Standardized Maths and Verbal Questions such as the ones used in SATs, Chronology of Perceived Discrimination Scale (CPDS), International Personality Item Pool (IPIP-NEO); Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Alzheimer's Disease, Vascular Dementia, Dementia, Memory Impairment
Interventions: Metformin, Placebos; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 55 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prostate Cancer, Bladder Cancer, Erectile Dysfunction, Incontinence
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 87,820 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Erectile Dysfunction
Interventions: GID SVF-2; Device
Lead sponsor: GID BIO, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Erectile Dysfunction
Interventions: Tissue Genesis Cell Isolation System; Device
Lead sponsor: Tissue Genesis; Industry
Eligibility: 40 Years to 70 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 2
States / cities: San Diego, California • Houston, Texas

Conditions: Breastfeeding, Postpartum Sexual Dysfunction, Vaginal Atrophy
Interventions: Estradiol, Vaginal Moisturizer; Drug · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Erectile Dysfunction
Interventions: Shock Wave therapy (SWT), Platelet Rich Plasma (PRP), Sham SWT, Placebo Saline; Device · Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 30 Years to 80 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Respiration Rate, Monitoring, Physiologic
Interventions: Chest Worn Respiratory Rate Monitor; Device
Lead sponsor: Perin Health Devices; Industry
Eligibility: 22 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Premature Ejaculation
Interventions: OnabotulinumtoxinA, Normal Saline; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 6
States / cities: San Diego, California • Torrance, California • Middlebury, Connecticut + 3 more

Conditions: Neurofibromatosis Type 1
Interventions: AlgometRx Nociometer(R); Device
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Year to 120 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Monochromatic, L- and S-cone Modulation Only, L- and M-cone Modulation Only, M and S-cone Modulation Only
Interventions: Color; Other
Lead sponsor: Rochester Institute of Technology; Other
Eligibility: Up to 35 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Physiologic Monitoring
Interventions: Zephyr BioPatch; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Propofol, Anesthesia, fMRI
Interventions: Functional Magnetic Resonance Imaging (fMRI) with propofol; Combination Product
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: COPD
Interventions: Esophageal and gastric balloons, Respiratory Inductance Plethysmography (RIP) system, Sentec transcutaneous monitoring system, High-flow humidified nasal oxygen delivery system, CPAP (Positive Control); Other · Device
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Overweight
Interventions: Orforglipron, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 27
States / cities: Birmingham, Alabama • Pelham, Alabama • Santa Ana, California + 21 more

Conditions: Sexual Dysfunction, Physiological
Interventions: Ospemifene, Vaginal conjugated estrogens; Drug
Lead sponsor: Emory University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 4
States / cities: Atlanta, Georgia

Conditions: Diabetes Mellitus, Type 2, Hyperglycemia
Interventions: Physiologic Insulin Therapy, Sliding-Scale Insulin Therapy; Other
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40,391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Mineola, New York

Search by objective public record fields.

The Effects of a Nitrate Supplementation on Erectile Function

Ketamine Effects on Learning In Eating Disorders

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

Stress & Resilience Study

eRT Remote Health Monitoring

A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain

Online Emotional Response to Completing a Childhood Maltreatment Self-report Scale

Effect of Insulin Sensitizer Metformin on AD Biomarkers

Duke Urology Database and Specimen Bank

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction

Postpartum Vaginal Estrogen for Breastfeeding Patients

Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction

Respiratory Rate Validation Study

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Evaluating How Well Different Types of Light-sensitive Cells in the Eye Contribute to Its Focusing Ability

Performance Assessment of a Remote Patient Monitoring Device

Investigating Near-Threshold Perception During Anesthetic Sedation

Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction

Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital